MedPath

Multi-Component Breath Alcohol Intervention Phase 3

Not Applicable
Recruiting
Conditions
Alcohol Use
Alcohol Drinking
Drinking Behavior
Registration Number
NCT06994962
Lead Sponsor
Northeastern University
Brief Summary

This is the third stage of a three-stage, NIH-funded study to develop and test a multi-modal intervention concerning blood/breath alcohol concentration for young adults who drink heavily. The multimodal intervention will be made up of brief telehealth counseling and psychoeducation and use of three existing mobile technologies. The brief counseling/psychoeducation and mobile technologies provide personalized feedback regarding blood or breath alcohol content. The long-term goal of use of these mobile technologies will be to facilitate moderate drinking. However, the main goals of the proposed research are to learn more about feasibility of our procedures, perceived value of the technologies and ease of use from the research participants' points of view. In this third stage of the study, the investigators will conduct a randomized controlled trial building on the formative research conducted in Stages 1 and 2.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
90
Inclusion Criteria
  • Be between the ages of 18-25
  • Be able to read English and complete study evaluations
  • At least occasional heavy episodic drinking (i.e., 4 or more drinks for women and 5 or more drinks for men) over the prior 30 days
  • Frequent consumption of at least one alcoholic drink during a minimum of 12 days out of the prior 30 so that subjects will have multiple opportunities to use the moderate drinking technologies during the intervention period.
Exclusion Criteria
  • Severe substance use disorder
  • Be psychotic or otherwise severely psychiatrically disabled
  • Report a history of a medical condition that would contraindicate the consumption of alcohol (e.g., liver disease, cardiac abnormality, pancreatitis, diabetes, neurological problems, and gastrointestinal disorders)

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Primary Outcome Measures
NameTimeMethod
Technology utilization4-week field use period

Percentage of reported drinking days on which one reports that moderate drinking technology use has occurred

Acceptability4-week field use period

Score on acceptability subscale of Modified System Usability Scale

Usability4-week field use period

Score on acceptability subscale of Modified System Usability Scale

Secondary Outcome Measures
NameTimeMethod
Drinks per drinking day4-week field use period

Number of drinks per day during field testing period

Estimated blood alcohol content4-week field use period

Average estimated blood alcohol content reached on drinking days

Negative Consequences4-week field use period

Score on the Young Adult Alcohol Consequences Questionnaire

Trial Locations

Locations (1)

Northeastern University

🇺🇸

Boston, Massachusetts, United States

Northeastern University
🇺🇸Boston, Massachusetts, United States
Jade Martinez, B.S.
Contact
617-697-7169
ja.martinez@northeastern.edu
Allie Farone, M.S.
Contact
a.farone@northeastern.edu
Robert F Leeman, PhD
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.